Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?

By 26th Annual San Diego Heart Failure Symposium FEATURING Pam Taub

953 views

December 15, 2020

4 Comments

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Primer on Diabetes Management

Feat. S. Inzucchi

11:37

ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich

28:13

National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason

11:25

ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster

59:01

The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo

21:27

Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta

26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo

19:09

ACC 2023 Conference Coverage

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

Feat. J. Saseen

34:20

Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester

19:16

The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

31:02

Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar

24:02

Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus

19:48

ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano

10:59

Mayo Clinic Proceedings

What Is the Effect of Omega-3 on Cardiovascular Outcomes? Should Thi…

Feat. C. Lavie

08:50

The Texas Heart Institute

Inside the Studio with Drs. Joseph Rogers and Salim Virani - Current…

Feat. J. Rogers, S. Virani

14:19

UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin

42:25

Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Feat. A. Klein

Login

Login

Join VuMedi

Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?

Related Content